<DOC>
	<DOCNO>NCT00109941</DOCNO>
	<brief_summary>RATIONALE : Opioid growth factor may stop growth pancreatic cancer block blood flow tumor . PURPOSE : This phase II trial study well opioid growth factor work treat patient advanced pancreatic cancer remove surgery .</brief_summary>
	<brief_title>Opioid Growth Factor Treating Patients With Advanced Pancreatic Cancer That Can Be Removed By Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine growth inhibitory effect opioid growth factor ( [ Met^5 ] -enkephalin ) patient advance unresectable pancreatic cancer . Secondary - Determine pharmacokinetics drug patient . - Determine quality life patient treated drug . - Determine pain control , depression , nutritional status patient treat drug . OUTLINE : This open-label study . Patients receive opioid growth factor ( [ Met^5 ] -enkephalin ) IV 45 minute weekly . Treatment continue absence disease progression unacceptable toxicity . Quality life assess baseline , every 4 week study treatment , completion study treatment . Patients follow weekly survival . PROJECTED ACCRUAL : A total 50 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<mesh_term>Enkephalin , Methionine</mesh_term>
	<criteria>Inclusion criterion Diagnosis pancreatic cancer Advanced , unresectable disease Must fail OR refuse prior standard chemotherapy ( e.g. , gemcitabine fluorouracil ) pancreatic cancer Measurable disease radiography Age Over 18 Performance status Karnofsky 50100 % Hematopoietic Absolute neutrophil count ≥ 1,500/mm^3 WBC ≥ 3,500/mm^3 Hemoglobin ≥ 8.5 g/dL Platelet count ≥ 100,000/mm^3 Bilirubin ≤ 4.0 mg/dL ( stent allow ) PT INR ≤ 2 second control OR ≤ 1.8 ( unless warfarin ) renal &amp; metabolic BUN ≤ 30 mg/dL ( hydrate ) Creatinine ≤ 2.0 mg/dL Sodium ≥ 130 mmol/L Potassium ≥ 3.2 mmol/L Glucose 60300 mg/dL Pulse 60110 beats/minute Systolic blood pressure 90170 mm Hg Exclusion Criteria No primary CNS tumor know brain metastasis Cardiovascular congestive heart failure symptom coronary artery disease cardiac arrhythmia poorly control hypertension myocardial infarction within past year abnormal EKG asthma hronic obstructive pulmonary disease pregnant nursing Fertile patient must use effective contraception serious infection require antibiotic within past 2 week poorly control diabetes seizure disorder fever &gt; 37.8° C malignancy within past 5 year concurrent chemotherapy concurrent oral steroid concurrent radiotherapy Surgery within 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>